Skip to main content

Table 1 Lymphoma survivors’ characteristics at the time of survivorship assessment

From: Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study

 

Hodgkin lymphoma

N = 2023

Non-Hodgkin lymphomas

N = 1619

N

(%)

N

(%)

Age

 Mean (sd)

47.8

(12.3)

62.9

(12.7)

 Median (min - max)

46.8

(24–85)

63.9

(24–92)

 20–39 years

608

(30.1)

82

(5.1)

 40–49 years

573

(28.3)

189

(11.7)

 50–49 years

482

(23.8)

345

(21.3)

 60–69 years

268

(13.3)

548

(33.8)

 70–79 years

77

(3.8)

310

(19.1)

  ≥ 80 years

15

(0.7)

145

(9.0)

Gender

 Male

994

(49.1)

882

(54.5)

 Female

1029

(50.9)

737

(45.5)

Education level

 University

736

(37.2)

516

(33.6)

 High school

646

(32.6)

480

(31.2)

 College

479

(24.2)

282

(18.3)

 Elementary school

119

(6.0)

260

(16.9)

 Unspecified

43

 

81

 

Years since treatment start, mean (sd)

15.7

(7.6)

12.8

(4.5)

 5 to 9 years

423

(20.9)

511

(31.6)

 10 to 14 years

665

(32.9)

561

(34.6)

 15 to 19 years

469

(23.2)

362

(21.4)

  ≥ 20 years

466

(23.0)

185

(11.4)

Cohabitation status

 Living without partner

  Yes

398

(19.7)

436

(26.9)

  No

1625

(80.3)

1183

(73.1)

Body Mass Index (BMI)

 BMI ≥ 30 kg/m2

231

(11.4)

264

(16.3)

 BMI < 30 kg/m2

1792

(88.6)

1355

(83.7)

Self-reported health disorders

 Cardiovascular disorders a

  Yes

442

(21.9)

327

(20.2)

  No

1581

(78.1)

1292

(79.8)

 Pulmonary disorders a

  Yes

164

(8.1)

108

(6.7)

  No

1859

(91.9)

1511

(93.3)

 Severe infections a

  Yes

288

(14.2)

200

(12.4)

  No

1735

(85.8)

1419

(87.6)

 Musculoskeletal disorders a

  Yes

172

(8.5)

142

(8.8)

  No

1851

(91.5)

1477

(91.2)

 Anxiety

  Yes

184

(9.1)

216

(13.3)

  No

1839

(90.9)

1403

(86.7)

 Depression or suicide attempt

  Yes

251

(12.4)

153

(9.5)

  No

1772

(87.6)

1466

(90.5)

Number of self-reported health disorders excluding second cancers

 0

780

(38.5)

577

(35.6)

 1

423

(20.9)

382

(23.6)

 2

295

(14.6)

225

(13.9)

 3

202

(10.0)

162

(10.0)

  ≥ 4

323

(16.0)

273

(16.9)

History of second cancer

    

 Yes

61

(3.0)

127

(7.8)

 No

1962

(97.0)

1492

(92.2)

Fatigue assessment

 MFI scores, crude mean (sd b)

  General fatigue (2020/1605) c

44.8

(29.4)

42.5

(26.4)

  Physical fatigue (2018/1577)

38.6

(29.8)

36.7

(27.3)

  Reduced activity (2017/1587)

31.8

(26.4)

33.4

(23.9)

  Reduced motivation (2018/1585)

26.9

(24.4)

27.2

(23.4)

  Mental fatigue (2007/1586)

31.4

(27.4)

28.3

(25.2)

  1. aCardiovascular disorders: heart valve problem, heart rhythm disorder, heart failure, peripheral artery disease, stroke, thrombosis
  2. Pulmonary disorders: pleurisy, lung function deterioration, chronic obstructive pulmonary disease
  3. Severe infections: zona infection, herpes zoster, hepatitis B, hepatitis C, tuberculosis
  4. Musculoskeletal disorders: avascular necrosis of bone, muscular fibrosis, severe osteoarthritis
  5. bsd indicates standard deviation
  6. cNumber of Hodgkin and non-Hodgkin lymphoma survivors with fatigue assessment available